BHVN

Biohaven Pharmaceutical Holding Company Ltd.
BHVN

Overview Fund Activity
Delisted

BHVN was delisted on the 3rd of October, 2022.

Back to rankings

197 hedge funds and large institutions have $2.01B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2019 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 84 increasing their positions, 38 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
197
Holders Change
+27
Holders Change %
+15.88%
% of All Funds
4.29%
Holding in Top 10
11
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-8.33%
% of All Funds
0.24%
New
64
Increased
84
Reduced
38
Closed
34
Calls
$162M
Puts
$60.6M
Net Calls
+$102M
Net Calls Change
+$69.2M

Top Buyers

1
Capital International Investors
Capital International Investors
California
+$61M
2
CGT
Capital Guardian Trust
California
+$47.8M
3
Nuveen Asset Management
Nuveen Asset Management
Illinois
+$38.8M
4
TAL
TIG Advisors LLC
New York
+$33.2M
5
OIM
Oracle Investment Management
Connecticut
+$28.5M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$64.4M
2
SC
Samlyn Capital
New York
-$37.5M
3
RCMNY
Rubric Capital Management (New York)
New York
-$36.4M
4
VC
Vivo Capital
California
-$26M
5
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$18.6M
Name Holding Trade Value Shares
Change 		Shares
Change %
MNBTD
226
Moody National Bank Trust Division
Texas
– -$7K -128 Closed
RFC
227
Regions Financial Corp
Alabama
– -$5K -100 Closed
CHP
228
Cable Hill Partners
Oregon
– -$4K -86 Closed
NFG
229
Next Financial Group
Texas
– -$2K -41 Closed
6 7 8 9
10